Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Amgen Inc.

Symbol: AMGN     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
3.27%
Current Price
$177.16
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-10 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
5,286,000,000
5,557,000,000
1,055,000,000
4,502,000,000
2,030,000,000
2,472,000,000
1,992,000,000
35,151,000,000
63,997,000,000
53,165,000,000
10,832,000,000
7,358,000,000
3,705,000,000
26,301,000,000
33,024,000,000
413,000,000
1,845,000,000
 
879,000,000

Financials 2018

Update: 2019-06-10 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
6,001,000,000
6,230,000,000
1,096,000,000
5,134,000,000
2,752,000,000
2,382,000,000
1,928,000,000
37,618,000,000
66,416,000,000
53,916,000,000
12,500,000,000
6,945,000,000
4,419,000,000
29,304,000,000
33,929,000,000
-5,011,000,000
3,194,000,000
 
1,182,000,000

Q 3

2018-09-30
5,510,000,000
5,904,000,000
1,037,000,000
4,867,000,000
2,544,000,000
2,323,000,000
1,859,000,000
38,320,000,000
67,333,000,000
52,984,000,000
14,349,000,000
11,956,000,000
5,077,000,000
29,921,000,000
34,427,000,000
1,825,000,000
3,273,000,000
 
926,000,000

Q 2

2018-06-30
5,679,000,000
6,059,000,000
1,024,000,000
5,035,000,000
2,203,000,000
2,832,000,000
2,296,000,000
37,970,000,000
67,684,000,000
52,775,000,000
14,909,000,000
10,131,000,000
4,288,000,000
29,395,000,000
34,497,000,000
390,000,000
2,102,000,000
 
869,000,000

Q 1

2018-03-31
5,343,000,000
5,554,000,000
944,000,000
4,610,000,000
1,884,000,000
2,726,000,000
2,311,000,000
40,689,000,000
71,164,000,000
55,544,000,000
15,620,000,000
9,741,000,000
2,183,000,000
32,172,000,000
35,541,000,000
5,941,000,000
2,727,000,000
 
760,000,000

Financials 2017

Update: 2019-06-10 13:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
5,569,000,000
5,802,000,000
1,059,000,000
4,743,000,000
2,498,000,000
2,245,000,000
-4,264,000,000
49,476,000,000
79,954,000,000
54,713,000,000
25,241,000,000
3,800,000,000
1,152,000,000
41,678,000,000
35,342,000,000
800,000,000
3,012,000,000
 
1,043,000,000